Losartan Potassium
Product Images NDC 50090-5406

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 01)

Chemical structure of the active ingredient in LOSARTAN POTASSIUM 25 mg, showing the molecular framework with potassium ion (K+), chlorine, hydroxyl and aromatic rings.*

FDA Label Image

Image002 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 02)

A line graph comparing the percentage of patients with primary endpoint events over 66 study months between Atenolol (dotted line) and Losartan potassium (solid line). The graph shows a lower percentage for Losartan potassium. It includes an annotation of adjusted risk reduction: 13%, p=0.021.*

FDA Label Image

Image003 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months for Atenolol versus Losartan potassium. The graph shows two lines, with Atenolol represented by a dotted line and Losartan potassium by a solid line, indicating a lower incidence with Losartan potassium. The graph also notes an adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Image004 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 04)

A clinical results chart comparing event rates and hazard ratios (95% CI) for Losartan Potassium and Atenolol. It shows primary composite and stroke events by patient subgroups including age, gender, race, ISH status, diabetes, and cardiovascular history. The chart uses forest plots to illustrate hazard ratios favoring Losartan Potassium or Atenolol.*

FDA Label Image

Image005 (03375ec9 0e3a 40c2 8c77 De5d9fd21876 05)

A line graph showing percentage of patients with events over 48 months comparing Losartan potassium and placebo groups. The solid line represents Losartan potassium, while the dotted line represents placebo. The graph notes a risk reduction of 16.1% with a p-value of 0.022.*

FDA Label Image

Label Image (Lbl500905406)

LOSARTAN POTASSIUM 25 mg tablet bottle label from A-S Medication Solutions. The label includes the product name, dosage strength, count of 30 film-coated tablets, storage instructions to protect from light and store at 77 degrees F, and packaging details. The NDC is 50090-5406.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.